AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...

President Trump’s threat to impose 30% tariffs on the European Union disrupted negotiations. From cars to wine, these are the ...

Trump has rolled back many of his steepest tariffs over recent months, including a sky-high levy on China, the top source of U.S. imports. In recent days, however, Trump announced plans to slap ...

President Trump and his administration have been studying new sectoral tariffs that could cover a broad part of the American ...

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...

Bourse ends at record in strongest session in three months. BHP rallies as CEO says China demand ‘resilient’. CSL posts its ...

As Washington presses ahead with additional tariffs on products from the European Union (EU) and beyond, European officials ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

The United States recent tariff announcements have cut down forecast for Southeast Asian economies, with the more ...

Bank of Ireland has revised upwards its economic forecasts for the year - if US tariffs remain at 10%. It predicts GDP growth of 8.1%, higher than the 3.5% growth previously forecast. The bank says ...

Trump said late Tuesday his administration will begin implementing pharmaceutical tariffs next month, making good on months of threats.